| Overview |
| bsm-0954M-PE-Cy5 |
| Endothelin-1(2C4) Monoclonal Antibody, PE-Cy5 Conjugated |
| WB |
| Human, Rat |
| Specifications |
| PE-Cy5 |
| Mouse |
| KLH conjugated synthetic peptide derived from human Endothelin-1 |
| 53-73/202 |
| Monoclonal |
| 2C4 |
| IgG |
| 1ug/ul |
| Purified by Protein G. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 1906 |
| EDN 1; EDN1; EDN1 protein; Endothelin1; ET 1; ET1; |
| Endothelins (ET) show potent constrictor activity in vascular and non-vascular smooth muscle. This family of 21-amino acid peptides exists in at least three isoforms - ET-1, ET-2, and ET-3, and is produced in endothelial and epithelial cells. ET's can mediate biological effects in cells and tissues, and have been shown to bind to an ET receptor in the lung, kidney, heart, and liver. Endothelin 1 is expressed in lung, placental stem villi vessels and in cultured placental vascular smooth muscle cells. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz